Pall Corporation Participates In A Consortium To Rapidly Develop A COVID-19 Vaccine
April 21, 2020
The consortium led by The University of Oxford is fast-tracking clinical trials beginning in April 2020 PORT WASHINGTON, N.Y. — Pall Corporation, a global leader in filtration, separation and purification, today announced its participation in a consortium led by the Jenner Institute, University of Oxford (Oxford, England), to rapidly develop, scale-up and produce a [...]
Signature Science Team Awarded Phase 3 Funding for IARPA Fun GCAT Program
April 21, 2020
Researchers from Signature Science, Rice University, University of Maryland, and Fraunhofer USA Center for Experimental Software Engineering will transition the computational tools developed to predict the function and threat potential of short DNA sequences to the end user community. AUSTIN, TEXAS – Signature Science, LLC has been selected to continue their support of the Intelligence [...]
Integral Molecular Receives NIAID Award to Combat COVID-19
April 21, 2020
PHILADELPHIA – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular $1 million to enable the application of Integral Molecular’s technology platforms to aid in the discovery of vaccines and therapeutics to combat COVID-19. Integral Molecular’s Shotgun Mutagenesis Epitope Mapping platform precisely identifies where antibodies bind to their target proteins, and will be [...]
April 21, 2020
Accelerating the development of innovative catalysts for sustainable, eco-efficient processes Norcross, GA, USA – Micromeritics Instrument Corp., a leader in material characterization technology, has delivered a bespoke high productivity catalyst evaluation unit, the Micromeritics Multi Catalyst Reactor 4 – MR-4, to the advanced Catalysis engineering (aCe) group at ETH Zurich (Switzerland) to accelerate work on [...]
April 21, 2020
MOBILion Systems, Inc. is partnering with Drs. Lance Wells and Michael Tiemeyer, pioneering researchers at the Complex Carbohydrate Research Center (CCRC), University of Georgia, to conduct COVID-19 glycan analysis using the company’s patented SLIM (Structures for Lossless Ion Mobility) separations technology. The new project aims to detail the glycosylation microheterogeneity in the spike glycoprotein that [...]
Sphere Fluidics receives Queen’s Award for Enterprise
April 21, 2020
Single cell analysis for therapeutic discovery recognized with prestigious business award for innovation Cambridge, UK: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, has be honored with a Queen’s Award for Enterprise for Innovation. The award recognizes the Company’s excellence in patenting, developing and globally commercializing single cell analysis [...]
Bio-Rad Introduces Anti-Ipilimumab Antibodies
April 21, 2020
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, has extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies that are specific for ipilimumab (Yervoy) and the ipilimumab/CTLA-4 drug-target complex. These highly specific and high-affinity antibodies are suitable for bioanalytical and [...]
New iPSC Master Cell Banks to Accelerate Development of Novel Cell Therapies
April 21, 2020
panCELLa and CCRM collaborate to benefit academia and industry Toronto, ON — Toronto-based panCELLa and CCRM have executed a collaboration agreement using novel technology to generate commercial-use and clinical-grade iPSC lines which will be made available to academia and industry to enable the development of new therapies. “panCELLa is an innovative company and a key [...]
April 20, 2020
Multi-Quadrupole ICP-MS, FT-IR and automation innovations provide testing and research performance, flexibility and ease of use WALTHAM, Mass. – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today expanded its analysis and automation portfolio for quality, safety and content testing. Geared for pharmaceutical, semiconductor, biomonitoring, food, materials and academia labs, the new [...]
MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology
April 20, 2020
London, UK / MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge Angels. The Company will develop its novel cell bioprocessing technology, utilising microfluidics to tackle the challenges associated with bioprocessing for cell [...]

